Keyhole Surgery Method Studied for Crohn's Disease in the Lower Small Intestine
Reviews a keyhole surgery technique for Crohn's disease in people aged 16 and over.
Plain-language title generated from the registry record
Registry title: Laparoscopic Right Hemicolectomy for Crohn's Disease of the Terminal Ileum Utilizing the Mesenteric Excision and Exclusion
Key facts
- Where
- Piraeus, GreeceSee the site
Where in Greece
- General Hospital Of Piraeus "Tzaneio"Piraeus, GreeceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tzaneio General Hospital
- Trial code
- NCT07231601
- Record updated
- 17 November 2025
- Original description
This study is designed for patients requiring surgery for Crohn's disease of the terminal ileum. A combination of laparoscopic segmental right colectomy with extended mesenteric excision and the Kono-s anastomosis will be utilized. Since this is a fairly new technique, the intra and post operative complications will be reviewed. Also endoscopic, clinical and surgical reoccurrence will be reviewed at certain predefined time points post operatively.Read full original descriptionShow less
Laparoscopic Mesenteric Excision and Exclusion for Crohn's Disease of the Terminal Ileum. A Greek Single Center Study.
This study is designed for patients requiring surgery for Crohn's disease of the terminal ileum. A combination of laparoscopic segmental right colectomy with extended mesenteric excision and the Kono-s anastomosis will be utilized. Since this is a fairly new technique, the intra and post operative complications will be reviewed. Also endoscopic, clinical and surgical reoccurrence will be reviewed at certain predefined time points post operatively.
Inclusion: Males and females aged >16 years; Ileocolic disease or disease of the terminal ileum with an indication for resection; Concurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, and anti-TNF therapy are permitted; All patients should have undergone a colonoscopy and a recent update of imaging (e.g. Ultrasound, MR enterography (or CT enterography if MR is contraindicated)); Ability to comply with protocol; Competent and able to provide written informed consent.
Exclusion: Clinically significant medical conditions within the six months before the operation : e.g. myocardial infarction, active angina, congestive heart failure or other conditions that would, in the opinion of the investigators, compromise the safety of the patient; Patients less than 16 years of age; History of cancer < 5 years which might influence patients prognosis; Inability to give informed consent; Emergent operation; Pregnant or breast feeding; Inability to follow up at 3, 6 and 12 months for postoperative assessment, imaging and endoscopy.